Menu Search
Equities

Yonghe Medical Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
L97:DUS

Yonghe Medical Group Co Ltd

Actions
  • Price (EUR)0.212
  • Today's Change0.002 / 0.95%
  • Shares traded--
  • 1 Year change+101.90%
  • Beta1.3434
Data delayed at least 15 minutes, as of Feb 16 2026 15:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Yonghe Medical Group Co Ltd is a holding company specializing in hair-related healthcare services. The Company offers one-stop hair-related healthcare services covering hair transplant, medical hair care, routine hair restoration and other ancillary services. The Company has built a brand matrix for the full industry chain which is centered on Yonghe Medical and comprised of Yonghe Hair Transplant for professional hair transplant service, Svenson for medical hair care service, Yonghe Fa Zhi Chu for female aesthetic hair transplant service, and Harvard for medical wig products. The Company also provides medical-grade hair health management service for patients facing hair diseases in a way using medical testing, diagnosis and personalized nursing treatment through Svenson Medical Hair Care Centers. The Company mainly conducts its businesses in domestic market.

  • Revenue in HKD (TTM)2.00bn
  • Net income in HKD-70.25m
  • Incorporated2020
  • Employees3.23k
  • Location
    Yonghe Medical Group Co LtdChina Nuclear E&C Building11/F,20 Ganluyuan NanliChaoyang DistrictBEIJING 100020ChinaCHN
  • Websitehttps://www.yonghegroup.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.